SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-21-041163
Filing Date
2021-08-10
Accepted
2021-08-09 20:34:36
Documents
61
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0621_virpaxpharma.htm   iXBRL 10-Q 652191
2 AMENDMENT TO THE COLLABORATION AND LICENSE AGREEMENT DATED APRIL 11, 2019, AS AM f10q0621ex10-3_virpaxpharma.htm EX-10.3 33219
3 AMENDMENT TO THE COLLABORATION AND LICENSE AGREEMENT DATED APRIL 11, 2019, AS AM f10q0621ex10-4_virpaxpharma.htm EX-10.4 9683
4 FIRST AMENDMENT TO THE AMENDED AND RESTATED VIRPAX PHARMACEUTICALS, INC. 2017 EQ f10q0621ex10-5_virpaxpharma.htm EX-10.5 9137
5 CERTIFICATION f10q0621ex31-1_virpaxpharma.htm EX-31.1 11042
6 CERTIFICATION f10q0621ex31-2_virpaxpharma.htm EX-31.2 11094
7 CERTIFICATION f10q0621ex32-1_virpaxpharma.htm EX-32.1 5598
8 GRAPHIC image_001.jpg GRAPHIC 47103
9 GRAPHIC ex10-3_001.jpg GRAPHIC 287982
  Complete submission text file 0001213900-21-041163.txt   4295945

Data Files

Seq Description Document Type Size
10 XBRL SCHEMA FILE vrpx-20210630.xsd EX-101.SCH 44436
11 XBRL CALCULATION FILE vrpx-20210630_cal.xml EX-101.CAL 24678
12 XBRL DEFINITION FILE vrpx-20210630_def.xml EX-101.DEF 199140
13 XBRL LABEL FILE vrpx-20210630_lab.xml EX-101.LAB 391775
14 XBRL PRESENTATION FILE vrpx-20210630_pre.xml EX-101.PRE 208644
15 EXTRACTED XBRL INSTANCE DOCUMENT f10q0621_virpaxpharma_htm.xml XML 387020
Mailing Address 1554 PAOLI PIKE #279 WEST CHESTER PA 19380
Business Address 1554 PAOLI PIKE #279 WEST CHESTER PA 19380 484-875-3195
Virpax Pharmaceuticals, Inc. (Filer) CIK: 0001708331 (see all company filings)

IRS No.: 821510982 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40064 | Film No.: 211158090
SIC: 2834 Pharmaceutical Preparations